开云app官网登录入口网页版-官方正版

#血栓性微血管病#

14篇内容 | 1170人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2188287, encodeId=edf7218828e45, content=<a href='/topic/show?id=90494486837' target=_blank style='color:#2F92EE;'>#妊娠期#</a> <a href='/topic/show?id=7a3c89103c6' target=_blank style='color:#2F92EE;'>#血栓性微血管病#</a> <a href='/topic/show?id=77d611135375' target=_blank style='color:#2F92EE;'>#LDH/AST#</a>, objectTitle=LDH/AST比值是妊娠期血栓性微血管病鉴别诊断的未来工具：摘要, objectType=article, longId=812652, objectId=0e3b812652f5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/black-surgeon-giving-instruction-to-medical-team-TMPFGNZ.jpg, objectUrl=/article/show_article.do?id=0e3b812652f5, replyNumber=0, likeNumber=83, createdTime=2024-02-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0e3b812652f5, moduleTitle=LDH/AST比值是妊娠期血栓性微血管病鉴别诊断的未来工具：摘要, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0e3b812652f5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2004079, encodeId=261820040e928, content=<a href='/topic/show?id=7a3c89103c6' target=_blank style='color:#2F92EE;'>#血栓性微血管病#</a>, objectTitle=J Clin Oncol：纳索普利单抗治疗造血干细胞移植相关血栓性微血管病的效果和安全性, objectType=article, longId=724762, objectId=4a8ee24762f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a8ee24762f1, replyNumber=0, likeNumber=117, createdTime=2023-01-20, rootId=0, userName=yangcx0915, userId=4723380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a8ee24762f1, moduleTitle=J Clin Oncol：纳索普利单抗治疗造血干细胞移植相关血栓性微血管病的效果和安全性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4a8ee24762f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004078, encodeId=5bd520040e8c3, content=<a href='/topic/show?id=7a3c89103c6' target=_blank style='color:#2F92EE;'>#血栓性微血管病#</a>, objectTitle=Ann Hematol：急性移植物抗宿主病增加骨髓增生异常综合征患者移植相关血栓性微血管病预测模型的风险和准确性, objectType=article, longId=302301, objectId=32c8302301b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32c8302301b4, replyNumber=0, likeNumber=89, createdTime=2022-06-27, rootId=0, userName=yangcx0915, userId=4723380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32c8302301b4, moduleTitle=Ann Hematol：急性移植物抗宿主病增加骨髓增生异常综合征患者移植相关血栓性微血管病预测模型的风险和准确性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=32c8302301b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004077, encodeId=7c7c20040e761, content=<a href='/topic/show?id=7a3c89103c6' target=_blank style='color:#2F92EE;'>#血栓性微血管病#</a>, objectTitle=成人血栓性微血管病急性和持续性肾损害的指标, objectType=article, longId=189148, objectId=7f4318914808, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f4318914808, replyNumber=0, likeNumber=75, createdTime=2020-04-03, rootId=0, userName=yangcx0915, userId=4723380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f4318914808, moduleTitle=成人血栓性微血管病急性和持续性肾损害的指标, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7f4318914808)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004074, encodeId=46b620040e4a0, content=<a href='/topic/show?id=7a3c89103c6' target=_blank style='color:#2F92EE;'>#血栓性微血管病#</a>, objectTitle=Akari的补体抑制剂Nomacopan治疗小儿造血干细胞移植相关血栓性微血管病，获得FDA快速通道指定, objectType=article, longId=177725, objectId=7f3b1e772586, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f3b1e772586, replyNumber=0, likeNumber=96, createdTime=2020-05-24, rootId=0, userName=yangcx0915, userId=4723380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f3b1e772586, moduleTitle=Akari的补体抑制剂Nomacopan治疗小儿造血干细胞移植相关血栓性微血管病，获得FDA快速通道指定, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7f3b1e772586)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004073, encodeId=628720040e31b, content=<a href='/topic/show?id=7a3c89103c6' target=_blank style='color:#2F92EE;'>#血栓性微血管病#</a>, objectTitle=Blood：ADAMTS13缺陷和补体过度激活协同导致血栓性微血管病, objectType=article, longId=177655, objectId=766e1e765529, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=766e1e765529, replyNumber=0, likeNumber=79, createdTime=2019-12-02, rootId=0, userName=yangcx0915, userId=4723380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=766e1e765529, moduleTitle=Blood：ADAMTS13缺陷和补体过度激活协同导致血栓性微血管病, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=766e1e765529)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004076, encodeId=443720040e6ea, content=<a href='/topic/show?id=7a3c89103c6' target=_blank style='color:#2F92EE;'>#血栓性微血管病#</a>, objectTitle=儿童造血干细胞移植相关的血栓性微血管病：Nomacopan关键性III期临床试验, objectType=article, longId=185186, objectId=397c185186ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=397c185186ea, replyNumber=0, likeNumber=77, createdTime=2020-10-12, rootId=0, userName=yangcx0915, userId=4723380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=397c185186ea, moduleTitle=儿童造血干细胞移植相关的血栓性微血管病：Nomacopan关键性III期临床试验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=397c185186ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004075, encodeId=898720040e509, content=<a href='/topic/show?id=7a3c89103c6' target=_blank style='color:#2F92EE;'>#血栓性微血管病#</a>, objectTitle=Akari的补体抑制剂nomacopan治疗造血干细胞移植相关血栓性微血管病变，获得FDA的孤儿药指定, objectType=article, longId=178530, objectId=2cdd1e853070, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cdd1e853070, replyNumber=0, likeNumber=96, createdTime=2020-03-06, rootId=0, userName=yangcx0915, userId=4723380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cdd1e853070, moduleTitle=Akari的补体抑制剂nomacopan治疗造血干细胞移植相关血栓性微血管病变，获得FDA的孤儿药指定, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2cdd1e853070)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004072, encodeId=a80f20040e22f, content=<a href='/topic/show?id=7a3c89103c6' target=_blank style='color:#2F92EE;'>#血栓性微血管病#</a>, objectTitle=Blood：血栓性微血管病变是三代TKI 帕纳替尼诱发的心血管毒性的潜在机制, objectType=article, longId=163453, objectId=730b163453fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=730b163453fc, replyNumber=0, likeNumber=117, createdTime=2020-02-13, rootId=0, userName=yangcx0915, userId=4723380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=730b163453fc, moduleTitle=Blood：血栓性微血管病变是三代TKI 帕纳替尼诱发的心血管毒性的潜在机制, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=730b163453fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004071, encodeId=1a9620040e17a, content=<a href='/topic/show?id=7a3c89103c6' target=_blank style='color:#2F92EE;'>#血栓性微血管病#</a>, objectTitle=J Rheumatol：伴肾活检血栓性微血管病变的狼疮性肾炎临床结局及临床病理相关性, objectType=article, longId=163152, objectId=24831631529d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24831631529d, replyNumber=0, likeNumber=76, createdTime=2019-10-03, rootId=0, userName=yangcx0915, userId=4723380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24831631529d, moduleTitle=J Rheumatol：伴肾活检血栓性微血管病变的狼疮性肾炎临床结局及临床病理相关性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=24831631529d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004070, encodeId=77ba20040e00c, content=<a href='/topic/show?id=7a3c89103c6' target=_blank style='color:#2F92EE;'>#血栓性微血管病#</a>, objectTitle=Blood：血栓性微血管病变是BCR-ABL1酪氨酸激酶抑制剂帕纳替尼引发心血管毒性的原因之一, objectType=article, longId=159627, objectId=aaa415962ed1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aaa415962ed1, replyNumber=0, likeNumber=67, createdTime=2019-10-12, rootId=0, userName=yangcx0915, userId=4723380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aaa415962ed1, moduleTitle=Blood：血栓性微血管病变是BCR-ABL1酪氨酸激酶抑制剂帕纳替尼引发心血管毒性的原因之一, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=aaa415962ed1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004069, encodeId=9a332004069bd, content=<a href='/topic/show?id=7a3c89103c6' target=_blank style='color:#2F92EE;'>#血栓性微血管病#</a>, objectTitle=嗜血细胞综合征并发血栓性微血管病肾损害一例, objectType=article, longId=123445, objectId=5f2c123445c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f2c123445c1, replyNumber=0, likeNumber=73, createdTime=2018-10-14, rootId=0, userName=yangcx0915, userId=4723380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f2c123445c1, moduleTitle=嗜血细胞综合征并发血栓性微血管病肾损害一例, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5f2c123445c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004068, encodeId=4c802004068ae, content=<a href='/topic/show?id=7a3c89103c6' target=_blank style='color:#2F92EE;'>#血栓性微血管病#</a>, objectTitle=KIDNEY INT：高血压相关的血栓性微血管病患者可出现补体异常！, objectType=article, longId=88902, objectId=6e4b88902ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e4b88902ff, replyNumber=0, likeNumber=89, createdTime=2017-04-24, rootId=0, userName=yangcx0915, userId=4723380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e4b88902ff, moduleTitle=KIDNEY INT：高血压相关的血栓性微血管病患者可出现补体异常！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6e4b88902ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004067, encodeId=f3cf200406e90, content=<a href='/topic/show?id=7a3c89103c6' target=_blank style='color:#2F92EE;'>#血栓性微血管病#</a>, objectTitle=2016梅奥CAP-TMA疾病小组共识——血栓性微血管病的护理路径发布, objectType=article, longId=74916, objectId=0579e49165c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0579e49165c, replyNumber=0, likeNumber=67, createdTime=2017-03-27, rootId=0, userName=yangcx0915, userId=4723380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0579e49165c, moduleTitle=2016梅奥CAP-TMA疾病小组共识——血栓性微血管病的护理路径发布, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0579e49165c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004066, encodeId=4ae320040665b, content=<a href='/topic/show?id=7a3c89103c6' target=_blank style='color:#2F92EE;'>#血栓性微血管病#</a>, objectTitle=NEJM：血栓性微血管病全新诊疗进展, objectType=article, longId=39731, objectId=78aa39e311d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78aa39e311d, replyNumber=0, likeNumber=122, createdTime=2014-10-14, rootId=0, userName=yangcx0915, userId=4723380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78aa39e311d, moduleTitle=NEJM：血栓性微血管病全新诊疗进展, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=78aa39e311d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

血栓性微血管病

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#妊娠期# #血栓性微血管病# #LDH/AST#

LDH/AST比值是妊娠期血栓性微血管病鉴别诊断的未来工具：摘要

2024-02-20发表于上海

yangcx0915 (审核中...)

前往app查看评论内容

#血栓性微血管病#

J Clin Oncol：纳索普利单抗治疗造血干细胞移植相关血栓性微血管病的效果和安全性

2023-01-20

yangcx0915 (审核中...)

前往app查看评论内容

#血栓性微血管病#

Ann Hematol：急性移植物抗宿主病增加骨髓增生异常综合征患者移植相关血栓性微血管病预测模型的风险和准确性

2022-06-27

yangcx0915 (审核中...)

前往app查看评论内容

#血栓性微血管病#

成人血栓性微血管病急性和持续性肾损害的指标

2020-04-03

yangcx0915 (审核中...)

前往app查看评论内容

#血栓性微血管病#

Akari的补体抑制剂Nomacopan治疗小儿造血干细胞移植相关血栓性微血管病，获得FDA快速通道指定

2020-05-24

yangcx0915 (审核中...)

前往app查看评论内容

#血栓性微血管病#

Blood：ADAMTS13缺陷和补体过度激活协同导致血栓性微血管病

2019-12-02

yangcx0915 (审核中...)

前往app查看评论内容

#血栓性微血管病#

儿童造血干细胞移植相关的血栓性微血管病：Nomacopan关键性III期临床试验

2020-10-12

yangcx0915 (审核中...)

前往app查看评论内容

#血栓性微血管病#

Akari的补体抑制剂nomacopan治疗造血干细胞移植相关血栓性微血管病变，获得FDA的孤儿药指定

2020-03-06

yangcx0915 (审核中...)

前往app查看评论内容

#血栓性微血管病#

Blood：血栓性微血管病变是三代TKI 帕纳替尼诱发的心血管毒性的潜在机制

2020-02-13

yangcx0915 (审核中...)

前往app查看评论内容

#血栓性微血管病#

J Rheumatol：伴肾活检血栓性微血管病变的狼疮性肾炎临床结局及临床病理相关性

2019-10-03

yangcx0915 (审核中...)

前往app查看评论内容

#血栓性微血管病#

Blood：血栓性微血管病变是BCR-ABL1酪氨酸激酶抑制剂帕纳替尼引发心血管毒性的原因之一

2019-10-12

yangcx0915 (审核中...)

前往app查看评论内容

#血栓性微血管病#

嗜血细胞综合征并发血栓性微血管病肾损害一例

2018-10-14

yangcx0915 (审核中...)

前往app查看评论内容

#血栓性微血管病#

KIDNEY INT：高血压相关的血栓性微血管病患者可出现补体异常！

2017-04-24

yangcx0915 (审核中...)

前往app查看评论内容

#血栓性微血管病#

2016梅奥CAP-TMA疾病小组共识——血栓性微血管病的护理路径发布

2017-03-27

yangcx0915 (审核中...)

前往app查看评论内容

#血栓性微血管病#

NEJM：血栓性微血管病全新诊疗进展

2014-10-14

科室
- - 订阅+
  - 更多科室
工具
服务